Aethlon Medical Enters Agreement with Institutional Investor for $3.3M Financing
Aethlon Medical announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 595,897 shares of common stock, together with warrants to purchase up to an aggregate 1,042,820 shares of common stock, in a private placement priced at-the-market under Nasdaq rules. The combined effective offering price for each share of common stock and accompanying warrants is $4.03. The warrants will have an exercise price of $4.03 per share, will be exercisable upon shareholder approval, and will expire on the five and one-half year anniversary from such date of shareholder approval. The gross proceeds to the company from the private placement and warrant inducement are estimated to be approximately $3.3M before deducting the placement agent's fees and other estimated offering expenses. The offering is expected to close on or about December 8, 2025, subject to the satisfaction of customary closing conditions. Maxim Group is acting as the sole placement agent in connection with the offering.
